GI & Endoscopy

Los Angeles-based Cedars-Sinai researchers analyzed more than 1,598 social media posts to determine patients' biggest concerns with inflammatory bowel disease.

GI Dynamics' EndoBarrier had its CE Mark suspended over nonconformances related to its quality management system.

The European Medicines Agency's Committee for Medicinal Products for Human Use issued a negative opinion of XBiotech's Lead mAb Xilonix, which treats advanced colorectal cancer, GEN reports.

Here are the five most read gastroenterology/endoscopy stories from May 15 to May 19, 2017.

Nader Youssef, MD, is a gastroenterologist at Hillsborough, N.J.

Here are five new or newly announced ASCs and facilities offering GI services.

Here are five gastroenterologists making headlines the week of May 15, 2017.

Takeda Pharmaceuticals and Marvel Custom Solutions revealed the second chapter of The Unbeatables adventures on May 19 for World IBD Day.

A study published in the Journal of Crohn's and Colitis examined the safety and efficacy of Salix Pharmaceuticals' budesonide multimatrix.

Neil Price, MD, Elizabeth Lindsey, MD and Mark Miller, MD, formed GastroIntestinal Health Partners, The Wilson Post reports.